Group 1: Shareholder Information - As of May 20, 2025, the number of shareholders is 38,986, an increase of 25 from May 10, 2025 [1][2] Group 2: Manufacturing Orders and Production - The company has a sufficient backlog of orders in the manufacturing sector for 2025, with production and sales showing growth compared to the previous year [2][3] Group 3: Acquisition Progress - The acquisition of Xinjiang Yibao Mining Resources Exploration and Development Co., Ltd. is ongoing, with no acquisition agreement signed yet [4][5] - The company is committed to adhering to the disclosure obligations set by the Shenzhen Stock Exchange regarding the acquisition [3][5] Group 4: Dividend Policy - The company retains undistributed profits primarily for operational needs, research and development, and project investments, with a focus on long-term shareholder interests [6]

Group 1: R&D Investment and Achievements - In 2024, the company's R&D expenses reached CNY 56.53 million, representing a year-on-year increase of 13.19% [2] - Key R&D projects include the approval of the drug "Perindopril" in December 2024 and the development of "Maltose Iron Gel" [2] Group 2: Financial Performance - In 2024, the company achieved an operating income of CNY 847 million, a growth of 5.92% year-on-year, and a net profit attributable to shareholders of CNY 42.19 million, up 67.45% [5] - The increase in performance was driven by revenue growth, reduced financial expenses related to financial liabilities, and increased government subsidies [5] Group 3: Market Position and Future Plans - The company is focusing on multi-channel sales strategies for its smoking cessation drug, with expectations of continued high growth this year [6] - There are currently three companies competing in the domestic market for smoking cessation drugs [6] - The company has no current plans for mergers or acquisitions but will disclose any future plans promptly [6] Group 4: Shareholder Engagement and Financial Health - The decline in net assets is primarily due to the acquisition of minority shareholder equity in a subsidiary and obligations related to share buybacks [4] - The company emphasizes balancing profit distribution with reinvestment needs to enhance investor confidence [5]

Core Viewpoint - China Software has received approval from the Shanghai Stock Exchange for its application to issue shares to specific investors, pending final approval from the China Securities Regulatory Commission (CSRC) [1][2]. Summary by Sections Issuance Details - The total amount to be raised from the issuance is not to exceed 200 million yuan, with net proceeds intended for research and development of various operating systems [1][2]. - The projects include: 1. Integrated mobile and fixed terminal operating system development with an investment of 150 million yuan, raising 100 million yuan 2. Cloud-based server operating system development with an investment of 120 million yuan, raising 80 million yuan 3. Embedded operating system capability platform construction with an investment of 30 million yuan, raising 20 million yuan - The total investment across all projects is 300 million yuan, with 200 million yuan to be raised [2]. Share Issuance Specifications - The shares to be issued are domestic RMB ordinary shares (A-shares) with a par value of 1 yuan per share [2]. - The issuance price is set at 22.19 yuan per share, which is not less than 80% of the average trading price over the previous 20 trading days [2]. - The number of shares to be issued will not exceed 90,130,689 shares, representing 10.60% of the total shares before the issuance and not exceeding 30% of the total share capital prior to the issuance [2]. Related Party Transactions - The issuance targets include China Electronics and China Electronics Investment, with China Electronics being the actual controller of the company [3]. - The company will adhere to legal regulations and internal procedures for related party transactions [3]. - The control of the company will remain unchanged post-issuance, with the controlling shareholder being unchanged [3]. Sponsorship - The sponsor for this issuance is CITIC Securities Co., Ltd., with representatives Zhang Dawei and Zhong Ling [3].

Core Viewpoint - The report provides a verification of Shenzhen Qingyi Optoelectronics Co., Ltd.'s pre-investment of self-raised funds into fundraising projects and payment of issuance expenses, confirming compliance with regulatory requirements [1][3]. Group 1: Management and Auditor Responsibilities - The management of Qingyi Optoelectronics is responsible for providing accurate and complete information in accordance with the relevant regulations and ensuring that the content is truthful and free from misleading statements [2]. - The auditor's responsibility is to independently verify the information provided by the management and to issue a verification conclusion based on the audit procedures performed [2][3]. Group 2: Fundraising Overview - The company has raised a total of RMB 1.2 billion (120,000 million) through a targeted issuance of 48 million shares at a price of RMB 25 per share, with net proceeds amounting to RMB 1.187 billion (118,700.94 million) after deducting issuance-related expenses [5][6]. - The funds were verified by Tianjian Accounting Firm, which issued a verification report confirming the funds' arrival in the company's regulatory account [5].

公司于 2025 年 5 月 15 日召开 2024 年年度股东大会，审议并通过了《关于 提请股东大会延长授权董事会办理以简易程序向特定对象发行股票相关事宜的 议案》。 （二）本次发行履行的监管部门注册程序 《关 | 股票简称：晶华新材 | | 股票代码：603683 | | --- | --- | --- | | 上海晶华胶粘新材料股份有限公司 | | | | A 以简易程序向特定对象发行 | | 股股票 | | 发行情况报告书 | | | | 保荐人（主承销商） | | | | （上海市黄浦区中山南路 | | 119 号东方证券大厦） | | 二〇二五年五月 | | | | 发行人全体董事、监事、高级管理人员声明 | | | | 本公司全体董事、监事、高级管理人员承诺本发行情况报告书不存在虚假记 | | | | 载、误导性陈述或重大遗漏，并对其真实性、准确性和完整性承担相应的法律责 | | | | 任。 | | | | 全体董事： | | | | 周晓南 周晓东 | | 白秋美 | | 丁冀平 马轶群 | | 俞 昊 | | 陈国颂 | | | | 全体监事： | | | | 矫 立 施卫红 | | 韦家 ...

Core Viewpoint - Changbai Mountain Tourism Co., Ltd. is in the process of issuing A-shares to specific investors, having received approval from the Shanghai Stock Exchange, pending final registration from the China Securities Regulatory Commission [1] Group 1: Issuance Details - The company plans to issue A-shares to no more than 35 specific investors, including various institutional and individual investors, with cash subscriptions only [4] - The total amount to be raised from the issuance is capped at 235.8495 million yuan, with net proceeds intended for investment in the Changbai Mountain Volcano Hot Spring Phase II and tourism transportation equipment enhancement projects [5][6] - The issuance will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 80,001,000 shares [5] Group 2: Financial Adjustments - The initial fundraising target was 435.8495 million yuan, which has been adjusted down to 235.8495 million yuan, while the intended projects remain unchanged [3] - The total investment for the Changbai Mountain Volcano Hot Spring Phase II project is 536.4892 million yuan, with 200 million yuan expected to be funded from the issuance [6] Group 3: Shareholding Structure - As of the announcement date, the company has a total share capital of 266,670,000 shares, with the controlling shareholder, Construction Group, holding 59.45% [7] - Post-issuance, Construction Group's shareholding will remain above 45.73%, ensuring no change in control of the company [7] Group 4: Regulatory Updates - The company has extended the validity period for the shareholder resolution regarding the issuance by an additional 12 months, now set to expire on December 20, 2025 [2] - A change in the sponsoring representative from Northeast Securities has been made to ensure the orderly progress of the issuance project [7]

股票简称：隆平高科 股票代码：000998 本公司全体董事、监事及高级管理人员承诺本上市公告书不存在虚假记载、 误导性陈述或重大遗漏，并对其真实性、准确性、完整性承担相应的法律责任。 公司监事签名： 袁定江 张 伟 邹振宇 袁隆平农业高科技股份有限公司 年 月 日 袁隆平农业高科技股份有限公司 向特定对象发行 A 股股票 上市公告书 保荐人（主承销商） 二〇二五年五月 发行人全体董事、监事、高级管理人员声明 本公司全体董事、监事及高级管理人员承诺本上市公告书不存在虚假记载、 误导性陈述或重大遗漏，并对其真实性、准确性、完整性承担相应的法律责任。 公司董事签名： | 刘志勇 | 张 | 坚 桑 | | 瑜 | | --- | --- | --- | --- | --- | | 许靖波 | 罗永根 | | 张 | 林 | | 李皎予 | 李少昆 | 刘贵富 | | | | | | 袁隆平农业高科技股份有限公司 | | | 年 月 日 发行人全体董事、监事、高级管理人员声明 发行人全体董事、监事、高级管理人员声明 本公司全体董事、监事及高级管理人员承诺本上市公告书不存在虚假记载、 误导性陈述或重大遗漏，并对其真实性 ...

青岛德固特节能装备股份有限公司 证券代码：300950 证券简称：德固特 | | 与可持续发展能力。具体使用安排及详细信息，请您持续关注公司后续发布 | | | | | --- | --- | --- | --- | --- | | | 的相关公告，谢谢您对公司的关心和支持！ | | | | | | 4、胶州的朋友说董事长人不错，我因为相信董事长人品买了公司股票，已 | | | | | | 持有 2 年多。我想问的是现在国家及青岛市均鼓励上市公司利用并购重 | | | | | | 组等举措提升市值，近期上市公司并购案例显著增加，公司是否将主动 | | | | | | 作为，积极寻求整合机会以巩固竞争优势？ | | | | | | 答：尊敬的投资者您好，感谢您对德固特的关心与支持！公司始终秉持 | | | | | | | 战略发展目标，持续关注行业整合机会与市场动态，积极探索包括并购在内 | | | | | | | 的多种业务拓展方式，以优化资源配置、提升核心竞争力及实现可持续发 | | | | | | | 展。公司将严格按照相关法律法规及监管要求，及时履行信息披露义务，请 | | | 您持续关注公司在法定信息 ...

5月10日，瑞晨环保（301273）发布2025年度向特定对象发行股票预案，本次向特定对象发行的对象为 公司实控人陈万东。 2022年公司违规超额度使用募集资金1.28亿元，暴露出内控缺陷。此次定增资金用途仅为"补充流动资 金"，而公司2024年末资产负债率仅19.48%，处于行业低位，资金必要性存疑。若资金再次被挪作他 用，中小股东如何维权？ 瑞晨环保近三年业绩呈现断崖式下滑：营业收入从2022年的4.39亿元降至2024年的2.82亿元，归母净利 润由盈转亏，2024年亏损3204万元，2025年一季度续亏2231万元。在此背景下，2.3亿元补流方案被质 疑。 （注：本文结合AI工具生成，不构成投资建议。市场有风险，投资需谨慎。） MACD金叉信号形成，这些股涨势不错！ 瑞晨环保此次向实控人陈万东定向增发2.3亿元，发行价定为17.68元/股，较公告前一日收盘价25.42元 折价30%。尽管该价格符合"不低于前20个交易日股价均价的80%"的监管要求，但其合理性仍引发市场 争议。 公司长期以来股价破发，当前股价较发行价37.89元已跌去33%。在股价长期低迷的情况下，以更低价 格向实控人增发，可能进一步打 ...

截至预案披露日，江泽星尚未持有汇纳科技股份。 2025年5月9日，江泽星实际控制的金石一号、宝金石一号与汇纳科技控股股东、实际控制人张宏俊签署 了《股份转让协议》，江泽星与上市公司签署了《附条件生效的股份认购协议》，张宏俊将其持有的汇 纳科技18,017,132股股份（（占上市公司股份总数的15.00%）及其所对应的所有股东权利和权益转让给 江泽星实际控制的金石一号、宝金石一号。汇纳科技拟向特定对象发行股票，江泽星拟认购汇纳科技发 行的股份，以增强其对汇纳科技的控制权。本次发行股份完成后，江泽星预计最高将持有汇纳科技 36,000,000股股份，结合《股份转让协议》约定的转让股份合计控制汇纳科技54,017,132股股份（约占汇 纳科技届时股份总数的34.60%）。 上述协议转让股份、向特定对象发行股票完成后，汇纳科技控股股东、实际控制人变更为江泽星。本次 向特定对象发行股票不会导致汇纳科技股权分布不具备上市条件。 中国经济网北京5月12日讯 汇纳科技（300609）(300609.SZ)近日发布2025年度向特定对象发行A股股票 预案，本次向特定对象发行股票募集资金金额不超过人民币73,872.00万元（含 ...